"Clinical Pathway and Application of Ginkgo Leaf Dropping Pills for Vascular Diseases" was well received by experts

Editor's note

From November 16th to 18th, 2018, the "National Clinical Pathway Implementation Management Forum (2018) and China's Clinical Discipline Standardization Construction Concord Summit" guided by the National Health Commission's Medical Administration and Hospital Administration was successfully held in Chengdu, Sichuan. In the "Clinical Pathway and Application of Ginkgo Leaf Dropping Pills for Vascular Diseases Sub-forum", several expert teams reported on the research progress and clinical experience in the treatment of vascular diseases with Ginkgo Leaf Dropping Pills. Finally, Professor Jin Youyu, a famous Chinese pharmacologist, expressed his strong interest and deep concern for Ginkgo biloba products by explaining the concept of Chinese and Western medicine and tracing the development history of Ginkgo biloba preparations at home and abroad. The research provides invaluable advice and guidance.

From November 16th to 18th, 2018, nearly 600 experts and scholars in the field of medical and health care from across the country gathered in Chengdu, Sichuan, to participate in the China Research Institute of Chinese Academy of Medical Sciences and Peking Union Medical College under the guidance of the Medical Administration and Hospital Administration of the National Health Commission. The "National Clinical Pathway Implementation Management Forum 2018 and China's Clinical Discipline Standardization Construction Concord Summit" jointly sponsored by the Hospital Society. This forum fully discussed the theme of "clinical pathway management and standardized construction of clinical disciplines". The meeting was broadcast live online simultaneously, and about 10,000 medical workers in China watched the live broadcast to participate in the study.

"Clinical Pathway and Application of Ginkgo Leaf Dropping Pills for Vascular Diseases Sub-forum", as one of the theme meetings of the Clinical Pathway Implementation Management Forum, was successfully held in the Grand Ballroom 1 on the fifth floor of the Kempinski Hotel Chengdu.

This sub-forum combines the current research results and progress of Ginkgo Leaf Dropping Pills, invites relevant clinical authoritative experts to give lectures, publishes and interprets the clinical pathway interpretation of Ginkgo Leaf Dropping Pills, and discusses the latest scientific research progress and drug analysis of Ginkgo Leaf Dropping Pills!

This forum is divided into two halves. Professor Gao Rui, chief researcher of the National Engineering Laboratory for Clinical Efficacy and Safety Evaluation of Traditional Chinese Medicine, served as the moderator of the first half of the forum. Professor Li Hongge of Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology conducted "Interpretation of Clinical Pathway Interpretation of Vascular Diseases"; Professor Dong Bo of Shandong Provincial Hospital talked about "The Relationship between Coronary Heart Disease and Arteriosclerosis and Endothelial Cell Damage and Its Treatment"; Professor Wang Aiwu of Shandong Provincial Hospital made the "Prescription Analysis of Ginkgo Leaf Dropping Pills in Our Hospital for Many Years and Evaluation of Combined Western Medicine for Vascular Diseases". Professor Lin Likai from Wuhan University Hospital Management Institute served as the moderator of the second half of the forum. Professor Gao Rui, chief researcher of the National Engineering Laboratory for Clinical Efficacy and Safety Evaluation of Traditional Chinese Medicine, introduced the "Single-case Randomized Controlled Trial of Ginkgo Leaf Dropping Pills in the Treatment of Coronary Heart Disease Complicated with Impaired Glucose Regulation"; Director Yu Jinyang of Guangdong Provincial Adverse Drug Reaction Monitoring Center Xiang Xiang We made the "Summary Report on Post-marketing Safety Evaluation of Ginkgo Leaf Dropping Pills".

Experts mainly interpret the multiple diseases that Ginkgo biloba dripping pills are included in the clinical pathway interpretation, and analyze and affirm from clinical application practice that ginkgo biloba dripping pills can well protect vascular endothelium, treat blood and treat veins, which is very consistent with traditional Chinese medicine. The theory of "synthetic treatment of blood and veins", and the various drug departments and diseases, the curative effect is accurate, and the progress and results of the single-case randomized controlled trial and post-marketing safety research of Ginkgo Leaf Dropping Pills are currently being exchanged and shared. Subsequently, Zhang Jianbing, deputy general manager of Wanbangde Pharmaceutical Group, introduced the "Introduction to the Operation of the Collaborative Innovation Alliance of Ginkgo Leaf Dropping Pills for Medical Research and Enterprises".

An important guest invited by the conference, Professor Jin Youyu, one of the founders of my country's pharmacology and a famous Chinese pharmacologist, was very interested in our research on Ginkgo biloba dropping pills. He insisted on standing and gave us a valuable speech for more than 40 minutes. Through the explanation of the concept of Chinese and Western medicine, and the retrospect of the development history of ginkgo biloba preparations at home and abroad, he expressed his strong interest and deep concern for ginkgo biloba products. The follow-up research of Ginkgo Biloba Dropping Pills has provided very valuable suggestions and guidance. We express our sincere admiration and gratitude for Mr. Jin's dedication and selfless dedication to the country's medical cause in his later years.

The sub-forum also brought together a number of clinical front-line experts from all over the country to exchange and discuss on the application of Ginkgo biloba drop pills in vascular diseases.

This sub-forum not only made a phased summary of the progress of clinical practice research of Ginkgo Leaf Dropping Pills at this stage, but also established a platform for experts in the field of vascular diseases of Ginkgo Leaf Dropping Pills to communicate and discuss together. At the same time, Wanbangde Pharmaceutical Group will also continue to be committed to the practice and promotion of clinical pathways, and to provide China and the world with high-quality Ginkgo biloba products with sufficient evidence-based evidence, controllable quality throughout the process, stable and reliable efficacy, and high safety in combination. effort!

The scene of the sub-forum meeting of clinical pathway and application of ginkgo leaf drop pills for vascular diseases

Professor Jin Youyu, a famous Chinese pharmacologist, delivered a speech

Group photo of participating experts